Edison Investment Research is terminating coverage on Crossject (ALCJ). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
16 May 2018
Crossject - Termination of coverage
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Crossject - Termination of coverage
Edison Investment Research is terminating coverage on Crossject (ALCJ). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.